Annual Drug Patent Expirations for AFINITOR
Afinitor is a drug marketed by Novartis and Novartis Pharm and is included in two NDAs. It is available from one supplier. There are five patents protecting this drug and three Paragraph IV challenges.
Drug patent litigation for AFINITOR.
This drug has forty-four patent family members in twenty-four countries.
The generic ingredient in AFINITOR is everolimus. One supplier is listed for this compound. Additional details are available on the everolimus profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
